Literature DB >> 2904376

Kynurenic acid and AP5 distinguish between NMDA receptor agonists.

T L Williams1, T W Stone, N R Burton, D A Smith.   

Abstract

Quantitative analysis of responses to amino acids in mouse cortical slices has indicated that the antagonists kynurenate and 2-amino-5-phosphonopentanoic acid distinguish between ibotenate and both N-methyl-D-aspartate (NMDA) and quinolinate. This result is consistent with the existence of NMDA-receptor subtypes.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2904376     DOI： 10.1016/0014-4886(88)90232-4

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


  3 in total

Review 1.  A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/glycine/ion channel receptor macrocomplex.

Authors:  P L Wood; T S Rao; S Iyengar; T Lanthorn; J Monahan; A Cordi; E Sun; M Vazquez; N Gray; P Contreras
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

2.  Two types of steady-state desensitization of N-methyl-D-aspartate receptor in isolated hippocampal neurones of rat.

Authors:  I V Chizhmakov; N I Kiskin; O A Krishtal
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

3.  Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.

Authors:  C B Carroll; V Holloway; J M Brotchie; I J Mitchell
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.